Price Alert

Astellas Pharma Inc. (ALPMY)

OTC: ALPMY · Real-Time Price · USD

11.33

0.15 (1.34%)

At close: Aug 15, 2025, 3:58 PM

11.30

-0.26%

After-hours: Aug 15, 2025, 03:58 PM EDT

Astellas Pharma Balance Sheet Statement

Financials in JPY. Fiscal year is April - March.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	188.37B	335.69B	376.84B	315.99B	326.13B
Short-Term Investments	29.94B	28.78B	19.78B	21.3B	5.56B
Long-Term Investments	18.99B	144.42B	134.75B	131.68B	136.89B
Other Long-Term Assets	153.25B	45.59B	10.28B	9.53B	9.91B
Receivables	632.52B	534.99B	427.96B	382.46B	343.18B
Inventory	297.26B	248.74B	174.39B	153.07B	164.08B
Other Current Assets	53.25B	46.54B	50.98B	50.54B	33.64B
Total Current Assets	1,201.3B	1,194.7B	1,050B	923.35B	872.59B
Property-Plant & Equipment	328.92B	293.74B	286.46B	269.04B	264.62B
Goodwill & Intangibles	1,538.9B	1,872.5B	890.91B	926.46B	935.44B
Total Long-Term Assets	2,138.2B	2,374.9B	1,406.6B	1,409B	1,401B
Total Assets	3,339.5B	3,569.6B	2,456.5B	2,332.4B	2,273.6B
Account Payables	187.84B	185.19B	140.24B	130.74B	124.78B
Deferred Revenue	n/a	n/a	5.14B	32.39B	8.39B
Short-Term Debt	266.53B	472.28B	75B	157.73B	136.1B
Other Current Liabilities	572.69B	589.74B	505.66B	366.55B	323.1B
Total Current Liabilities	1,061.6B	1,285.7B	726.03B	687.41B	592.37B
Long-Term Debt	564.89B	447.74B	50B	n/a	n/a
Other Long-Term Liabilities	194.43B	240.15B	111.07B	130.34B	232.98B
Total Long-Term Liabilities	764.68B	687.89B	222.53B	184.68B	295.14B
Total Liabilities	1,826.3B	1,973.6B	948.56B	872.09B	887.51B
Total Debt	831.43B	920.02B	200.01B	212.74B	278.26B
Common Stock	103B	103B	103B	103B	103B
Retained Earnings	740.94B	809.4B	908.16B	944.26B	953.29B
Comprehensive Income	n/a	n/a	340.64B	247.51B	167.37B
Shareholders Equity	1,513.3B	1,596B	1,508B	1,460.3B	1,386.1B
Total Investments	18.99B	124.38B	134.75B	131.68B	136.89B